Rapid analysis of local data to inform off-label tocilizumab use early in the COVID-19 pandemic.

MLA

Morgan, Camille E., et al. “Rapid Analysis of Local Data to Inform Off-Label Tocilizumab Use Early in the COVID-19 Pandemic.” Healthcare (Amsterdam, Netherlands), vol. 9, no. 4, Dec. 2021, p. 100581. EBSCOhost, https://doi.org/10.1016/j.hjdsi.2021.100581.

APA

Morgan, C. E., Rimland, C. A., Bell, G. J., Kim, M. K., Hedrick, T., Marx, A., Bramson, B., Swygard, H., Napravnik, S., Schmitz, J. L., Carson, S. S., Fischer, W. A., Eron, J. J., Gay, C. L., & Parr, J. B. (2021). Rapid analysis of local data to inform off-label tocilizumab use early in the COVID-19 pandemic. Healthcare (Amsterdam, Netherlands), 9(4), 100581. https://doi.org/10.1016/j.hjdsi.2021.100581

Chicago

Morgan, Camille E, Casey A Rimland, Griffin J Bell, Min K Kim, Tanner Hedrick, Ashley Marx, Brian Bramson, et al. 2021. “Rapid Analysis of Local Data to Inform Off-Label Tocilizumab Use Early in the COVID-19 Pandemic.” Healthcare (Amsterdam, Netherlands) 9 (4): 100581. doi:10.1016/j.hjdsi.2021.100581.